As a group of Regulatory, QA, and Pharmacovigilance consultants, they cater to small to medium-sized pharmaceutical companies, recognizing the ever-changing regulatory landscape and offering assistance in various areas including registration, publishing, pharmacovigilance, and lifecycle maintenance.
Their services extend to tracking regulatory changes, providing submission services to regulators and Competent Authorities worldwide, and preparing and submitting updates to product characteristics and labeling.
The company, founded in 2018, focuses on addressing the evolving regulatory needs of pharmaceutical companies, with a particular emphasis on the UK market.
As of now, there is no publicly available information regarding the last investment and the investors involved in the company.